FAS and Alzheimer disease: Based on the results, we selected 5 lncRNAs (BC200, NDM29, NEAT1, FAS-AS1 and GAS5-AS1) as potential candidates for qPCR validation in the total cohort consisting of 50 AD and 50 healthy controls to measure the relative expression.